Convalescent Plasma for Infectious Diseases: Historical Framework and Use in COVID-19

Convalescent plasma has emerged as a promising therapeutic agent for patients with coronavirus disease 2019 (COVID-19), has received emergency use authorization, and is being widely used during the COVID-19 pandemic. Passive antibody therapy via plasma or serum has been successfully used to treat in...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clin Microbiol Newsl
Autori principali: Ripoll, Juan G., van Helmond, Noud, Senefeld, Jonathon W., Wiggins, Chad C., Klassen, Stephen A., Baker, Sarah E., Larson, Kathryn F., Murphy, Brenna M., Andersen, Kylie J., Ford, Shane K., Casadevall, Arturo, Joyner, Michael J.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Elsevier 2021
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7862032/
https://ncbi.nlm.nih.gov/pubmed/33564204
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clinmicnews.2021.02.001
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi